You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company, still collecting utility data, anticipates that this more complex analysis will lead to better personalization of health and wellness strategies for its clients.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
In PNAS this week: DNA regulation in islet cells, algorithm predicts regulatory element marks in various tissues, and more.
The study seeks to identify biomarkers that can help personalize treatment for patients by identifying signs of rapid decline in kidney function.
The collaborators plan to collect samples that will allow them insight into participants' microbiomes in order to understand disease mechanisms over time.
Danish researchers link the expression of three genes to being obese, but metabolically healthy, the Guardian reports.
In Nature this week: DNA methylation patters can uncover people at increased risk of diabetes, and more.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
By studying variants in PCSK9, researchers reported the therapies targeting the gene would have some of the same effects as statins.
The company plans to recruit one million patients from Mexico over three years and then expand to Columbia, Argentina, and Brazil.
The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.
New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.
In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.